Assertio Holdings, Inc. (ASRT)
Assertio Holdings, Inc. is a commercial pharmaceutical company, which engages in acquisitions, licensing, and mergers. The firm focuses on portfolio of neurology, inflammation, and pain medications. Its products include INDOCIN, Sympazan, Otrexup, SPRIX, CAMBIA, and Zipsor. The company was founded on August 7, 1995 and is headquartered in Lake Forest, IL.
Address
100 S. SAUNDERS ROAD
LAKE FOREST, IL 60045
Founded
1995
Number of Employees
53
Website
http://www.assertiotx.com
Buyback
| Buyback Data | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | Average |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| $ Amount Purchased ($ in 000s) |
- | - | - | - | - | - | - | $415 | $873 | $8,106 | $280 | $2,418 |
| Average Price | - | - | - | - | - | - | - | $3.30 | $2.00 | $6.93 | $0.92 | $4.75 |
| # Shares Purchased | - | - | - | - | - | - | - | 125,817 | 435,392 | 1,170,007 | 305,229 | 509,111 |
| Buyback Performance | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | Average |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Return to Date | - | - | - | - | - | - | - | -69.7% | -50.1% | -85.6% | 9.2% | -78.9% |
| S&P 500 Return to Date | - | - | - | - | - | - | - | 31.7% | 37.3% | 31.3% | 7.4% | 26.9% |
| Excess Total Return | - | - | - | - | - | - | - | -101.3% | -87.4% | -116.9% | 1.8% | -105.9% |
| Quartile Rank |
|
|
|
|
|
|
|
|
|
|
|
|
| Percentile Rank | - | - | - | - | - | - | - | 6% | 11% | 1% | 59% | 5% |
Buyback returns calculated using weighted average buyback price over the last 10 years and comparing to current day stock price value. S&P 500 used as benchmark for excess return.
Insider Transactions
Filters
Keyboard Shortcuts: Show (a) | Close (Esc)
Never miss an email alert when insiders at ASRT make a trade.
Creating a free account takes less than one minute